|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Trends in treatment and overall survival among patients with proximal esophageal cancer显示文摘BACKGROUND The management of proximal esophageal cancer differs from that of tumors located in the mid and lower part of the esophagus due to the close vicinity of vital structures.Non-surgical treatment options like radiotherapy and definitive chemoradiation(CRT)have been implemented.The trends in(non-)surgical treatment and its impact on overall survival(OS)in patients with proximal esophageal cancer are unclear,related to its rare disease status.To optimize treatment strategies and counseling of patients with proximal esophageal cancer,it is therefore essential to gain more insight through real-life studies.AIM To establish trends in treatment and OS in patients with proximal esophageal cancer.METHODS In this population-based study,patients with proximal esophageal cancer diagnosed between 1989 and 2014 were identified in the Netherlands Cancer Registry.The proximal esophagus consists of the cervical esophagus and the upper thoracic section,extending to 24 cm from the incisors.Trends in radiotherapy,chemotherapy,and surgery,and OS were assessed.Analyses were stratified by presence of distant metastasis.Multivariable Cox proportional hazards regression analyses was performed to assess the effect of period of diagnosis on OS,adjusted for patient,tumor,and treatment characteristics.RESULTS In total,2783 patients were included.Over the study period,the use of radiotherapy,resection,and CRT in non-metastatic disease changed from 53%,23%,and 1%in 1989-1994 to 21%,9%,and 49%in 2010-2014,respectively.In metastatic disease,the use of chemotherapy and radiotherapy increased over time.Median OS of the total population increased from 7.3 mo[95%confidence interval(CI):6.4-8.1]in 1989-1994 to 9.5 mo(95%CI:8.1-10.8)in 2010-2014(logrank P<0.001).In non-metastatic disease,5-year OS rates improved from 5%(95%CI:3%-7%)in 1989-1994 to 13%(95%CI:9%-17%)in 2010-2014(logrank P<0.001).Multivariable regression analysis demonstrated a significant treatment effect over time on survival.In metastatic disease,median OS was 3.8 mo(95%CI:2.5-5.1)in 1989-1994,and 5.1 mo(95%CI:4.3-5.9)in 2010-2014(logrank P=0.26).CONCLUSION OS significantly improved in non-metastatic proximal esophageal cancer,likely to be associated with an increased use of CRT.Patterns in metastatic disease did not change significantly over time. | Judith de Vos-Geelen Sandra ME Geurts Liselot BJ Valkenburg-van Iersel Evelien JM de Jong Vivianne CG Tjan-Heijnen Margreet van Putten Valery EPP Lemmens Heike I Grabsch Nadia Haj Mohammad Frank JP Hoebers Chantal V Hoge Paul M Jeene Hanneke WM van Laarhoven Tom Rozema Marije Slingerland Grard AP Nieuwenhuijzen | 2019 | World Journal of Gastroenterology2019，25，47： | 2 |
| 2 | The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid rathritis显示文摘 | Frank CA Steven ME Danl AB | 1988 | ArthriRheum1988，31，3： | 1 |
| 3 | An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs显示文摘 | Farkouh ME Greenberg BP Frank J | | 0，，09： | 1 |
| 4 | Nogo-A is a myelin-associated neurite out-growth inhibitor and an antigen for monoclonal antibody IN-1 显示文摘 | Chen MS Huber AB van der Haar ME Frank M Schnell L Spillmann AA | 2000 | Nature2000，403，6768： | 1 |
| 5 | P53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx 显示文摘 | Frank JL Bur ME Garb JL | 1994 | Cancer1994，73，1： | 1 |
| 6 | Treatment of major depression with psychotherapy or psychotherapy - pharmacotherapy combinations显示文摘 | Thase ME Greenhouse JB Frank E | 1997 | Arch Gen Psychiatry1997，54，： | 1 |
| 7 | Mapping study of the parabrachial taste-responsive area for the anterior tongue in the golden hamster显示文摘 | Halsell CB Frank ME | 1991 | J Comp Neurol1991，306，4： | 1 |
| 8 | Persistence of taste buds in deneravated fungiform papillae显示文摘 | Whitehead MC Frank ME Hettinger TP | 1987 | Brain Res1987，405，19： | 1 |
| 9 | Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease 显示文摘 | Gressner S Jafarl ME Frank Y | 2009 | Clin Chim Acta2009，403，： | 1 |
| 10 | Thalidomide 显示文摘 | Franks ME Macpherson GR Figg WD | 2004 | Lancet2004，363，9423： | 1 |
| 11 | CREB : a mediator of Long-term memory from mollusks to mammals显示文摘 | Frank DA Greenberg ME | 1994 | Cell1994，79，1： | 1 |
| 12 | Polysomnographic studies of unmedicated depressed men before and after cognitive behavior therapy显示文摘 | Thase ME Reynolds III CF Frank E | 1994 | American Journal of Psychiatry1994，151，： | 1 |
| 13 | Technique of parastomal hernia repair using synthetic mesh显示文摘 | Franks ME Hrebinko RL | 2001 | Urology2001，57，3： | 1 |
| 14 | Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis 显示文摘 | Apter AJ Gent JF Frank ME | 1999 | Arch Otolaryngol Head Neck Surg1999，125，9： | 1 |
| 15 | Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 显示文摘 | Chen MS Huber AB van der Haar ME Frank M Schnell L Spillmarm AA | 2000 | Nature2000，403，6768： | 1 |
| 16 | Thalidomide 显示文摘 | Franks ME Macpherson GR Figg WD | 2004 | Lancet2004，363，9423： | 1 |
| 17 | The distinctiveness of ionic and nonionic bitter stimuli显示文摘 | Frank ME Bouverat BP MacKinnon BI | 2004 | Physiol Behav2004，80，： | 1 |
| 18 | Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 显示文摘 | Chen MS Huber AB van der Haar ME Frank M Schnell L Spillmann AA | 2000 | Nature2000，403，6768： | 1 |
| 19 | Partial adrenalec-tomy: the National Cancer Institute experience 显示文摘 | DINER EK FRANKS ME BEHARI A | 2005 | Urology2005，66，1： | 1 |
| 20 | Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1显示文摘 | Chen MS Huber AB van der Haar ME Frank M Schnell L Spillmann AA | 2000 | Nature2000，403，6768： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员